Hydrochlorothiazide, Cilazapril

INHIBACE PLUS 5 mg/12,5mg COMPRIMIDOS RECUBIERTOS CON PELICULA

12,5 mg + 5 mg comprimido recubierto con películaSpainMarketedAuthorised 30 Jun 1995

In other countries

The same active substances on other registers, the same brand first.

Inhibace PlusCanada · 5 MG + 12.5 MG · Tablet · Cheplapharm Arzneimittel GMBHSame brand
Apo-Cilazapril/HCTZCanada · 5 MG + 12.5 MG · Tablet · Apotex INCSame form
Teva-Cilazapril/HCTZCanada · 5 MG + 12.5 MG · Tablet · Teva Canada LimitedSame form
Prilazid® plusSerbia · 5mg+12.5mg · film tableta · Galenika Ad BeogradSame form
Vascase PlusBrazil · Produtos Roche Químicos e Farmacêuticos S.A.Same substance

Packs

Pack	Code	Status
INHIBACE PLUS 5 mg/12,5mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	686741

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Hydrochlorothiazide, Cilazapril

INHIBACE PLUS 5 mg/12,5mg COMPRIMIDOS RECUBIERTOS CON PELICULA

12,5 mg + 5 mg comprimido recubierto con películaSpainMarketedAuthorised 30 Jun 1995

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
INHIBACE PLUS 5 mg/12,5mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	686741

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAEMPS

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Hydrochlorothiazide, Cilazapril
Strength: 12,5 mg + 5 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Jun 1995
Registration: 60649
Marketing authorisation holder: Cheplapharm Arzneimittel Gmbh
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

Hydrochlorothiazide + Cilazapril · 12,5 mg + 5 mg · comprimido recubierto con película

SpainWithdrawn